Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution

The present paper reports, to the best of our knowledge for the first time, the efficacy and tolerability of the combination of interferon (IFN)α-2a in pegylated formulation and rituximab after a “priming” phase with IFN in the frontline treatment of hairy cell leukemia (HCL) in a profoundly immunos...

Descripción completa

Detalles Bibliográficos
Autores principales: Furlan, Anna, Rossi, Maria Cristina, Gherlinzoni, Filippo, Scotton, Piergiorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036287/
https://www.ncbi.nlm.nih.gov/pubmed/35466184
http://dx.doi.org/10.3390/hematolrep14020020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036287/
https://www.ncbi.nlm.nih.gov/pubmed/35466184
http://dx.doi.org/10.3390/hematolrep14020020

Ejemplares similares